<DOC>
	<DOCNO>NCT00003045</DOCNO>
	<brief_summary>Hyperthermia therapy may kill prostate cancer cell heat several degree body temperature . Radiation therapy use high-energy x-rays damage tumor cell . Combining hyperthermia radiation therapy may kill tumor cell . The purpose study determine ability hyperthermia combine radiation therapy patient hormonal therapy control prostate cancer .</brief_summary>
	<brief_title>Hyperthermia Plus Radiation Therapy Treating Patients With Nonmetastatic Advanced Prostate Cancer</brief_title>
	<detailed_description>The purpose study determine ability hyperthermia ( heat treatment produce sound wave ) combine radiation therapy patient hormonal therapy control prostate cancer . Hyperthermia refers use temperature 42 oC ( 107-6oF ) high treatment malignant tumor . Laboratory clinical report demonstrate tumor kill effect tumor heat 43oC ( 109oF ) 30-60 minute . Many study show hyperthermia improves kill effect radiation treatment many tumor . In clinical study , addition hyperthermia show beneficial tumor breast , urinary bladder head neck region combine radiation therapy . Investigators find improvement tumor response rate lengthen duration response . The propose study one first control study attempt prove usefulness hyperthermia patient prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Fever</mesh_term>
	<criteria>Inclusion Criteria Histologic confirmation prostate cancer . ( Slides obtain central review ) Clinical stage T2b , T2c , T3a , T3b disease define AJCC 4th edition stag manual ( see Appendix A ) No evidence metastatic disease ( bone , lymph node visceral ) base bone scan compute tomography Adequate hematologic function WBC &gt; 4000/mm3 platelet count &gt; 100 , 000/mm3 hematocrit &gt; 30 % An ECOG Performance Status zero one Age â‰¥ 18 A life expectancy 5 year ( exclude possible prostate related cause ) Exclusion Criteria : Prior history malignancy ( except nonmelanoma skin cancer ) Prior systemic therapy No prior chemotherapy No prior hormonal therapy recommend protocol Prior pelvic radiotherapy Medical problem ( abnormal bleeding propensity ) would make transrectal ultrasounddirected transperineal thermal probe placement hazardous . Patients severe insulindependent diabetes mellitus evidence neuropathy vaculopathy Patients unstable cardiac status include : Unstable angina pectoris medication Patients document myocardial infarction within six month protocol entry Congestive heart failure require medication Patients antiarrhythmic drug Severe hypertension ( diastolic BP &gt; 100 medication Patients cardiac pacemaker Severe cerebrovascular disease ( multiple CVA CVA within 6 month ) Severe COPD ( medication requiring , FEV 1 &lt; 50 % expect &lt; 1 liter ) Individuals appear unlikely tolerate require prolong stationary position treatment due emotional immaturity instability otherwise due mental incompetence .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
</DOC>